What is Trileptal (Oxcarbazepine)?
Trileptal is an antiepileptic drug (AED) containing oxcarbazepine, approved for treating partial-onset seizures (also called focal seizures) in adults and children. 1
Licensed Indications
Trileptal (oxcarbazepine) is FDA-approved for:
- Epilepsy - partial seizures with or without secondary generalized tonic-clonic seizures in adults and children aged 6 years and older 2
- Can be used as monotherapy (alone) or adjunctive therapy (with other seizure medications) 1
- In the US, approved as monotherapy in adults and as adjunctive therapy in children ≥4 years of age 1
How It Works
Oxcarbazepine works primarily by blocking voltage-sensitive sodium channels in the brain, which stabilizes overexcited nerve cell membranes and prevents seizure spread. 1 The drug also modulates calcium channels and increases potassium conductance, contributing to its anticonvulsant effects 1.
Key Pharmacological Features
Metabolism
- Oxcarbazepine is rapidly converted to its active metabolite MHD (10-monohydroxy derivative), which is responsible for most of the antiepileptic activity 1, 3
- The parent drug has a half-life of about 2 hours, while MHD has a half-life of about 9 hours 1
- Unlike carbamazepine, oxcarbazepine undergoes reductive metabolism rather than oxidation by cytochrome P-450 enzymes, resulting in fewer drug interactions 3, 4
Available Formulations
Critical Safety Considerations
Serious Risks Requiring Immediate Attention
1. Severe Cutaneous Adverse Drug Reactions (SCARs)
- HLA-B*15:02 carriers have markedly increased risk of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) 2, 5
- HLA-A*31:01 carriers have increased risk of drug reaction with eosinophilia and systemic symptoms (DRESS) and SJS/TEN 2, 5
- Patients allergic to carbamazepine are often allergic to oxcarbazepine - avoid if carbamazepine allergy exists 1
- The 2026 UK pharmacogenomics guideline recommends avoiding oxcarbazepine in HLA-B*15:02-positive patients and considering avoidance in HLA-A*31:01-positive patients 2
2. Hyponatremia (Low Sodium)
- Can cause nausea, confusion, tiredness, more frequent seizures, and headache 1
- Requires monitoring, especially in elderly patients 1
3. Multi-organ Hypersensitivity Reactions
- Can affect liver, blood cells, and other organs 1
- Watch for: fever, swollen glands, sore throat, unusual bruising/bleeding, severe fatigue, yellowing of skin/eyes 1
4. Suicidal Thoughts
- Like all AEDs, carries risk of suicidal ideation (approximately 1 in 500 patients) 1
Common Side Effects
The most frequent adverse effects include 1:
- Dizziness
- Somnolence (sleepiness)
- Diplopia (double vision)
- Fatigue
- Nausea and vomiting
- Ataxia (coordination problems)
- Headache
Drug Interactions
Oxcarbazepine has fewer drug interactions than carbamazepine but still requires attention: 1, 4
- Decreases effectiveness of oral contraceptives - alternative contraception methods should be used 1, 4
- Can increase phenytoin levels by 40% at doses above 1,200 mg 2
- Strong enzyme inducers (carbamazepine, phenobarbital, phenytoin) can reduce MHD levels by 30-40% 4
- Minimal effect on valproic acid and lamotrigine (unlike carbamazepine) 3
Dosing Considerations
- Take twice daily, with or without food 1
- Dose reduction of at least 50% required in patients with moderate to severe renal impairment (creatinine clearance <30 mL/min) 1
- Children may require higher weight-adjusted doses due to faster renal clearance 1, 4
- Never stop abruptly - can cause status epilepticus (continuous seizures) 1
Advantages Over Carbamazepine
Oxcarbazepine offers several clinical advantages over its predecessor carbamazepine: 3, 6
- Better tolerability with fewer side effects
- No autoinduction (more predictable dosing)
- Linear pharmacokinetics
- Fewer drug-drug interactions
- Lower risk of serious blood disorders (no reported agranulocytosis or aplastic anemia cases)
- Can be combined more effectively with other AEDs like valproate
Special Populations
- Pregnancy: Unknown if harmful to fetus; pregnancy registry available (1-888-233-2334) 1
- Breastfeeding: Passes into breast milk - discuss with healthcare provider 1
- Elderly: Higher drug exposure due to reduced renal clearance; requires sodium monitoring 1
- Children: Approved for ages 6+ (Europe) or 4+ (US for monotherapy); faster metabolism may require dose adjustments 1